Capital Signal

Starpharma Holdings Limited (ASX: SPL)

Sector: Health Care

Market cap: A$217M (as of 2 Nov 2026)

Biotechnology - development of dendrimer technology for pharmaceutical, life science and other applications.

Data as of 2 Nov 2026.

Recent capital raises

DateTypeAmountPriceDiscountSource
11 Aug 2026Rights issue$32M——Filing ↗
29 Oct 2020SPP$48.9M$1.50—Filing ↗

Substantial holders — latest moves

DateHolderMoveHoldingSource
7 Oct 2026ATV HOLDINGS PTY LTDIncrease—Filing ↗
11 Sept 2026UBS Group AG and its related bodies corporateEntry?% → 5.06%Filing ↗
31 Aug 2026UBS Group AG and its related bodies corporateExit—Filing ↗
24 Aug 2026UBS Group AG and its related bodies corporateEntry?% → 5.23%Filing ↗
13 Aug 2026UBS Group AG and its related bodies corporateDecrease8.58% → 7.05%Filing ↗

Director trades — on-market

DateDirectorTradeSource
16 Oct 2025Robert B. THOMASBought 450,000 Ordinary SharesFiling ↗
5 Nov 2024Robert B. THOMASBought 300,000 Ordinary SharesFiling ↗
23 Oct 2024Robert B. THOMASBought 500,000 Ordinary SharesFiling ↗
13 Sept 2024Dr Russell BasserBought 200,000 Ordinary SharesFiling ↗
2 Sept 2024Robert B. THOMASBought 350,000 Ordinary SharesFiling ↗

Cash and runway

MetricValueAs ofSource
CashA$34M30 Sept 2026Filing ↗
Runway5.9 quarters30 Sept 2026Filing ↗

Ask about SPL in Claude or ChatGPT

Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:

  • Has SPL raised money in the last year, and at what discount?
  • What was SPL's latest cash position and runway?

Setup guide for Claude, ChatGPT and other MCP clients →

Loading SPL…

Starpharma Holdings Limited (ASX: SPL): capital raises, holders, director trades | Capital Signal